Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Glenmark Pharmaceuticals Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

01 Aug 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Glenmark Pharmaceuticals Ltd (GLENMARK-IN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

31 Jul 2015 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for Glenmark Pharmaceuticals Ltd

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

16 Jul 2015 Wright Reports 56 $75.00

Is Glenmark Pharmaceuticals Ltd a Good Long-Term Investment?

03 Jun 2015 Sadif Analytics Prime 11 $25.00

MOSL: Glenmark Pharma ((Buy) - Results marred by one-offs - FY16 outlook robust

GLENMARK PHARMA 4QFY15: Results marred by one-offs; FY16 outlook robust (GNP IN, Mkt Cap USD3.2b, CMP INR865, TP INR950, 10%...

02 Jun 2015 Motilal Oswal Securities Ltd. 12 $127.00

Glenmark Pharmaceuticals (GNP) - Qtr. Update - Dated - June 01, 2015

Glenmark Pharma (Bloomberg: GNP IN, BUY, TP – Rs 960, 11% upside from CMP of Rs 865) While GNP’s Q4 adj. PAT (+24%/18% YoY...

01 Jun 2015 Axis Capital Limited 12 $127.00

Glenmark Pharmaceuticals Ltd.| Q4FY15 Result/Concall Update | Delay in ANDA approvals and currency fluctuation impacts earnings; maintain HOLD rating with revised PT of Rs808 (from Rs828 earlier)

Glenmark Pharmaceuticals Ltd.| Q4FY15 Result/Concall Update Delay in ANDA approvals and currency fluctuation impacts earning...

01 Jun 2015 IndiaNivesh Securities Pvt Ltd 6 $58.00

GLEN.NS - Event Transcript of Glenmark Pharmaceuticals Ltd conference call, May 31, 2015 / 11:00PM ET

Edited Event Transcript of GLEN.NS conference call, May 31, 2015 / 11:00PM ET Boston, Jun 1, 2015 (Thomson StreetEvents...

31 May 2015 Thomson Reuters StreetEvents 26 $75.00

MOSL: GLENMARK PHARMA (Buy) - Forex hit mars 3Q performance - imminent US launches to bolster growth

GLENMARK PHARMA 3QFY15: Forex hit mars 3Q performance; imminent US launches to bolster growth (GNP IN, Mkt Cap USD3.2b, CMP ...

16 Feb 2015 Motilal Oswal Securities Ltd. 12 $127.00

Glenmark Pharmaceuticals (GNP) - Qtr. Update - Dated - February 13, 2015

Glenmark Pharma (Bloomberg: GNP IN, BUY, TP – Rs 860, 12% upside from CMP of Rs 767) GNP’s Q3 PAT (-47% YoY) was 43% below...

13 Feb 2015 Axis Capital Limited 9 $92.00